Weiss Multi-Strategy Advisers’s Insmed INSM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,500	Closed	-$164K	–	560
2018 Q4	$164K	Sell	12,500 -2,500	-17%	-$39.9K	0.01%	418
2018 Q3	$303K	Buy	+15,000	New	+$339K	0.01%	480
2016 Q1	–	Sell	-11,200	Closed	-$203K	–	504
2015 Q4	$203K	Buy	+11,200	New	+$197K	0.01%	345

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Weiss Multi-Strategy Advisers's INSM Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Insmed (INSM) in Q1 2024, closing a stake of 70,000 shares — an estimated $2.17M sold.

Weiss Multi-Strategy Advisers first reported a position in INSM in Q2 2013 and held it in 31 quarters. The position peaked at $2.85M in Q4 2022. 288 funds tracked by Wall St. Rank hold INSM as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Insmed position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 70,000 Insmed shares in Q1 2024, an estimated $2.17M.
Weiss Multi-Strategy Advisers first reported a position in Insmed in Q2 2013 and held it in 31 quarters.
Weiss Multi-Strategy Advisers's Insmed position peaked at $2.85M in Q4 2022.
288 funds tracked by Wall St. Rank held Insmed as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.